Medtronic Inc. (NYSE:MDT) is under the spotlight at the IRS for profit-shifting practices that effectively cut its corporate tax rate in half.
The IRS targeted Medtronic in a $958 million lawsuit in U.S. Tax Court over the way the company shifted income to offshore units, according to Bloomberg.